Metabolomic biomarkers in gestational diabetes mellitus: a review of the evidence

S Alesi, D Ghelani, K Rassie, A Mousa - International Journal of …, 2021 - mdpi.com
Gestational diabetes mellitus (GDM) is the fastest growing type of diabetes, affecting
between 2 to 38% of pregnancies worldwide, varying considerably depending on diagnostic …

Biomarkers of aging

Aging Biomarker Consortium, H Bao, J Cao… - Science China Life …, 2023 - Springer
Aging biomarkers are a combination of biological parameters to (i) assess age-related
changes,(ii) track the physiological aging process, and (iii) predict the transition into a …

Review of methods for detecting glycemic disorders

M Bergman, M Abdul-Ghani, RA DeFronzo… - Diabetes research and …, 2020 - Elsevier
Prediabetes (intermediate hyperglycemia) consists of two abnormalities, impaired fasting
glucose (IFG) and impaired glucose tolerance (IGT) detected by a standardized 75-gram …

Omics-based biomarkers in the diagnosis of diabetes

WZ Gan, V Ramachandran, CSY Lim… - Journal of Basic and …, 2020 - degruyter.com
Diabetes mellitus (DM) is a group of metabolic diseases related to the dysfunction of insulin,
causing hyperglycaemia and life-threatening complications. Current early screening and …

[HTML][HTML] 1, 5 Anhydroglucitol in gestational diabetes mellitus

TA Pramodkumar, R Jayashri, K Gokulakrishnan… - Journal of Diabetes and …, 2019 - Elsevier
Abstract Objective 1, 5 Anhydroglucitol (1, 5 AG) is reported to be a more sensitive marker of
glucose variability and short-term glycemic control (1–2 weeks) in patients with type1 and …

Diagnostic value of glycemic markers HbA1c, 1, 5-anhydroglucitol and glycated albumin in evaluating gestational diabetes mellitus

B Saglam, S Uysal, S Sozdinler… - Therapeutic …, 2017 - journals.sagepub.com
Background: The oral glucose tolerance test (OGTT) is the current established method
performed worldwide to diagnose gestational diabetes mellitus (GDM). The purpose of this …

Serum 1, 5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status

H Su, X Ma, J Yin, Y Wang, X He, Y Bao, J Zhou… - Acta Diabetologica, 2017 - Springer
Aims Previous studies showed that serum 1, 5-anhydroglucitol (1, 5-AG) levels are
significantly reduced in patients with diabetes mellitus (DM). However, it remains unclear …

[PDF][PDF] Evaluation Of Serum 1, 5-Anhydroglucitol Levels among Type 2 Diabetic Patients in Basrah

SK Ajlan, SK Qasim - University of Thi-Qar Journal Of Medicine, 2020 - iasj.net
ABSTRACT Objective: To determine serum 1, 5-anhydroglucitol (1, 5-AG) levels among
patients with type 2 diabetes (T2D) in Basrah, and to evaluate the changes in 1, 5-AG levels …

Serum 1, 5-Anhydroglucitol Concentration as a Biomarker for Type 1 Diabetes in Adults and Children.

BR Martins, LC Gomes, KC Boritza… - Clinical …, 2019 - search.ebscohost.com
Abstract Background: Type 1 diabetes (T1D) is an autoimmune disease and the leading
form of diabetes among young white people. 1, 5-Anhydroglucitol (1, 5-AG), a nontraditional …

Evaluation of Serum 1, 5-Anhydroglucitol Levels as Hyperglycemic Indicator in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

A Vanagamudi, J Padmini - Journal of Diabetology, 2022 - journals.lww.com
Materials and Methods: The study group consisted of 60 type 2 diabetes patients aged 35–
55 years and 60 age-and sex-matched controls. 1, 5-AG plasma level, HbA1c, fructosamine …